Cite

HARVARD Citation

    Finn, R. et al. (n.d.). Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitro12. Hepatology. 57 (5), pp. 1838-1846. [Online]. 
  
Back to record